Question · Q3 2025
Glenn Mattson inquired about the reported decrease in pilot headsets/aviation heads-up display revenue, the sustainability of the significantly lower SG&A, and the role of the medical business in Kopin's two-year outlook, specifically regarding the HMDMD partnership.
Answer
CEO Michael Murray clarified that the decrease in pilot headsets revenue was a timing issue, a manufacturing-to-demand push. CFO Erich Manz stated the lower SG&A is not a new run rate, attributing it to one-time litigation accrual reductions. Michael Murray added that the appeal expense is a one-time $500,000, with SG&A normalizing in 2026. Michael Murray confirmed HMDMD's growth, its partnership with Carl Zeiss, and Kopin's work on other medical products, also noting increased interest in armored vehicle systems.
Ask follow-up questions
Fintool can predict
KOPN's earnings beat/miss a week before the call